Q: I initially bought a 1.5% position of COV but with the recent decline and me adding cash to other positions, it's now less than 0.7% of my portfolio...
I know you guys are not big fans of averaging down in bad momentum, but in this situation would you recommend doubling my position if I have some extra cash?
Leave it as it is or just sell since it has become such a small position?
Thank you!
Q: Hi 5i team,
Earlier in April they announced a financing deal and the stock price has been going lower ever since. On April 23 they announced a new dividend of .03 cents which means a DY of about 2%. It's not spectacular, but we like the 'confidence' that a dividend announcement brings, no? How long before the market reacts to this? Specifically, shouldn't some fund managers and institutional players jump onboard soon after, when there is a new dividend announcement for this stock? (and a corresponding uptick in the price). Thx, R.
Q: Edwards, a US company that you likely do not follow, has developed an minimally invasive medical device and procedure for replacing faulty valves in humans. This procedure has many advantages, includinding cost and recovery time, over the open heart procedure. While there is competition in this market Edwards appears to be growing the stock has not performed well recently and I am down about 8%. I am considering selling if my loss reaches 10%.
Would you please give me you opinion of this company if you follow it t all?
With appreciation,
Ed
Q: I know you don't cover US stocks but wanted to get your thoughts on Healthcare Services Group Inc. Given their current fundamentals is the recent decline overdone?Thank you.
Glen
Q: I've read that tjis conpany is significantly undervalued and it's shares have the potential to double in value by the end of the year. What are your thoughts?
I am looking to add some shares from one of the following companies and want to know at their current valuations, which would you choose if you had a 3-5 year time horizon?
Which stocks do you think have the potential to become 5, 10, or even 20 baggers over time? Would PBH, SIS, and PBL be on the list (or has their time past)? Also, can you rank the three in terms of which have the most growth going forward?
Q: 1st time in a long time that GUD is up sharply on the day(7.32% currently) on drug approval news .Have 4% position @ $10.16,so is it a good time to add some?Txs for u usual great views & services.Just imagine the reaction if it makes a big investment.
Q: Hi, I have a 1/3 position in Allergan (AGN), down about 40%. Michael Waterhouse, a Morningstar analyst, makes a strong case that Allergan is considerably undervalued. I’m thinking of adding to my position and would appreciate your opinion. I also hold full positons in GILD, CSH.UN and GUD, as part of a well-diversified portfolio.
Thanks, Kevin
Q: My local newspaper had an enlightening article on opioid prescriptions to treat chronic pain. The article stated that over 9 million prescriptions were filled "in Ontario alone" during 2015-2016. I found this number astounding considering the population is about 14 million which means one in every three people had this prescribed during that time which was an increase of 500,000 from three years previous to those dates.
Does this not mean Knight's announcement of Health Canada's approval of Probuphine for opioid treatment is a huge event? Why would they announce this after the close on a Friday - it seems like a big deal. What do you think?
Q: Just received report and the board would like to list on Nasdaq exchange.They want to reduce share holdings for a price to stay listed on exchange.Good or bad and should I buy more or wait for more results.I could buy 1000 shares and wait also.Very small % of portfolio
Q: News reports say Takeda is offering $66.20 in cash and stock for SHPG but stock currently trades at $160.16. Am I missing something? Aside from the takeover interest, is SHPG a good buy at this time